- Home
- ZVSA vs CRKN Comparison
ZVSA vs CRKN Comparison
Compare ZVSA & CRKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- CRKN
- Stock Information
- Founded
- ZVSA 2014
- CRKN 2015
- Country
- ZVSA United States
- CRKN United States
- Employees
- ZVSA N/A
- CRKN N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- CRKN Industrial Machinery/Components
- Sector
- ZVSA Health Care
- CRKN Technology
- Exchange
- ZVSA Nasdaq
- CRKN Nasdaq
- Market Cap
- ZVSA 2.5M
- CRKN 2.6M
- IPO Year
- ZVSA N/A
- CRKN N/A
- Fundamental
- Price
- ZVSA $1.10
- CRKN $0.16
- Analyst Decision
- ZVSA Strong Buy
- CRKN
- Analyst Count
- ZVSA 1
- CRKN 0
- Target Price
- ZVSA $240.00
- CRKN N/A
- AVG Volume (30 Days)
- ZVSA 243.8K
- CRKN 20.2M
- Earning Date
- ZVSA 11-14-2024
- CRKN 11-14-2024
- Dividend Yield
- ZVSA N/A
- CRKN N/A
- EPS Growth
- ZVSA N/A
- CRKN N/A
- EPS
- ZVSA N/A
- CRKN N/A
- Revenue
- ZVSA N/A
- CRKN $13,461,000.00
- Revenue This Year
- ZVSA N/A
- CRKN N/A
- Revenue Next Year
- ZVSA N/A
- CRKN N/A
- P/E Ratio
- ZVSA N/A
- CRKN N/A
- Revenue Growth
- ZVSA N/A
- CRKN 22715.25
- 52 Week Low
- ZVSA $0.98
- CRKN $0.15
- 52 Week High
- ZVSA $25.00
- CRKN $90.00
- Technical
- Relative Strength Index (RSI)
- ZVSA 41.83
- CRKN 14.04
- Support Level
- ZVSA $0.99
- CRKN $0.21
- Resistance Level
- ZVSA $1.20
- CRKN $0.38
- Average True Range (ATR)
- ZVSA 0.08
- CRKN 0.05
- MACD
- ZVSA 0.04
- CRKN 0.01
- Stochastic Oscillator
- ZVSA 54.55
- CRKN 6.36
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About CRKN Crown Electrokinetics Corp.
Crown ElectroKinetics Corp is a provider of DynamicTint. The company's technology allows any glass surface to transition between clear and dark in seconds. DynamicTint allows windows to transition from transparent to black. With applications to a wide array of windows, including commercial buildings, automotive sunroofs, and residential skylights, Crown partners with glass and film manufacturers for mass production and distribution. Its technology is a thin film that is powered by an electrically-charged pigment which not only replaces common window tints but is also a more sustainable alternative to traditional window treatments. It is supported by a robust patent portfolio.